SCHEMBL14587006

SCHEMBL14587006

O=C1CCc2ccc(OCCCN3CCN(c4ccc(O)c(Cl)c4Cl)CC3)cc2N1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 18/20 0.75
▸ DRD3 P35462 13/20 0.71
▸ DRD4 P21917 12/20 0.71
▸ HTR2A P28223 9/20 0.71
▸ DRD1 P21728 8/20 0.71
▸ DRD5 P21918 7/20 0.71
▸ MAOA P21397 3/20 0.71
▸ HTR1A P08908 2/20 0.71
▸ HTR2C P28335 2/20 0.71
▸ HTR2B P41595 2/20 0.71
▸ KCNH2 Q12809 2/20 0.71
▸ HTR3E A5X5Y0 1/20 0.71
▸ MEN1 O00255 1/20 0.71
▸ MLNR O43193 1/20 0.71
▸ HTR3B O95264 1/20 0.71
▸ ABCB11 O95342 1/20 0.71
▸ ESR1 P03372 1/20 0.71
▸ PGR P06401 1/20 0.71
▸ ADRB2 P07550 1/20 0.71
▸ CHRM2 P08172 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5609347 0.97 DRD2 (0.76) DRD2DRD3DRD4HTR2ADRD1
SCHEMBL30751117 0.97 DRD2 (0.76) DRD2DRD3DRD4HTR2ADRD1
SCHEMBL15486132 0.86 DRD2 (0.76) DRD2DRD3DRD4HTR2ADRD1
SCHEMBL29528854 0.86 DRD2 (0.76) DRD2DRD3DRD4HTR2ADRD1
SCHEMBL10571409 0.85 DRD2 (0.94) DRD2DRD3DRD4HTR2ADRD1
SCHEMBL14587008 0.84 DRD2 (0.66) DRD2DRD3DRD4HTR2ADRD1
SCHEMBL5608898 0.84 DRD2 (0.69) DRD2DRD3DRD4HTR2ADRD1
SCHEMBL30751116 0.84 DRD2 (0.69) DRD2DRD3DRD4HTR2ADRD1
Aripiprazole SCHEMBL29438823 0.83 DRD2 (1.00) DRD2DRD3DRD4HTR2ADRD1
Aripiprazole SCHEMBL982189 0.83 DRD2 (1.00) DRD2DRD3DRD4HTR2ADRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9125939-B2 Carbostyril derivatives and mood stabilizers for treating mood disorders OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2015-09-08 — — US disclosed
US-9125939-B2 Carbostyril derivatives and mood stabilizers for treating mood disorders OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2015-09-08 — — US disclosed
US-20070031513-A1 Carbostyril derivatives and mood stabilizers for treating mood disorders OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-02-08 — — US disclosed
US-20070031513-A1 Carbostyril derivatives and mood stabilizers for treating mood disorders OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-02-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070031513-A1 Carbostyril derivatives and mood stabilizers for treating mood disorders CHRNA6, GABBR1, CHRNA5 DRD2 29/4885DRD3 82/4885DRD4 75/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback